HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/24/2013 -- Advanced Micro Devices, Inc. (NYSE:AMD) shares gained 11.43% to $2.73 after the company announced that Charles Matar and Wayne Meretsky have joined the company to assume critical new engineering leadership roles driving hardware and software intellectual property (IP) development for AMD’s system-on-chip (SoC) solutions. Matar will draw upon his expertise in SoC and processor design to lead AMD’s SoC methodology and client SoC execution.
Can AMD Continue To Move Higher? Find Out Here
MAP Pharmaceuticals Inc. (NASDAQ:MAPP) shares jumped 58.60% and closed at $24.71 after Allergan Inc said that it would buy MAP Pharmaceuticals Inc for about $958 million in cash, to deepen its presence in the treatment of migraines in adults. Under the deal, Allergan will acquire 100 percent of the shares of MAP Pharmaceuticals at $25 per share. MAP Pharmaceuticals is developing Levadex, an orally inhaled drug for the acute treatment of migraines in adults. Levadex is currently under review by the U.S. Food and Drug Administration.
Will The MAPP Split Boost Share Price Among Huge Volatility? Find Out Here
Cree, Inc. (NASDAQ:CREE) had a monster day on Wednesday on strong earnings, up 7.38 to 40.85, or 22%, on 14.2 million shares. That’s the biggest volume in a very long time, going back as far as 2011. It formed a huge base that it built on, pulled back in January, stabilized, and broke out, not only through lateral resistance, but to the top of the channel, and closed at the very high end of the range. It was a very bullish occurrence. Look for an extension here to 44, the swing trade target. It may very exceed that and get into the upper end of the range at 46.
Where Is Cree, Inc. Headed Exactly After Achieving This Milestone? Find Out Here
KB Home (NYSE:KBH) shares increased 8.88% and closed at $18.63 in yesterday’s session after the company announced the pricing of concurrent underwritten public offerings of 5.5 million shares of common stock at public offering price of $18.25 per share (or up to 6.325 million shares if the underwriters exercise their option to purchase additional shares). The company also agreed to sell $200 million of 1.375% convertible senior notes due 2019 (or up to $230 million if the underwriters exercise their over-allotment option). The closing of both offerings is expected to occur on January 29, 2013.
Is KBH Showing Any Sign of Buy At The Current Market Price? Find Out Here
Groupon Inc (NASDAQ:GRPN) shares gained 5.27% to $5.09 in the last trading session. On Jan. 22, Milberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of purchasers of Groupon, Inc., common stock between May 14, 2012 and November 8, 2012.
Can GRPN Extend Rally? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)